- A consortium of West Coast children’s hospitals and universities is getting more than $6 million from the U.S. Food and Drug Administration to continue research and development of mHealth and telehealth technology for children.
The West Coast Consortium for Technology and Innovation in Pediatrics (CTIP), based at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC), has supported more than 120 programs in 15 states, including recent grants to mHealth innovators developing a low-cost infant microbiome monitoring device for home or clinic use, a novel short arm exoskeleton to help treat orthopedic fractures, an improved sound-delivery vest for treating respiratory conditions and a virtual reality system for treating pediatric chronic pain.
“Innovation in healthcare covers so much ground – from finding successful new methods of patient care to developing novel medical devices and digital health technologies – and the industry has yet to scratch the surface,” Omkar P. Kulkarni, MPH, CHLA’s newly appointed Chief Innovation Officer and a member of the CTIP leadership team, said in a press release. “Children’s Hospital Los Angeles has the expertise, experience and resources needed to lead the charge, and we are committed to pushing the boundaries of innovation to enhance the quality of care and health outcomes for the children we serve.”
Launched in 2011 and first supported by the FDA in 2013, the CTIP is one of only five centers across the country awarded an FDA Pediatric Device Consortium (PDC) grant, offered by the Office of Orphan Products Development (OOPD). The five-year grant is for $6.6 million.
Aside from CHLA and USC, other members of the consortium include the University of California, Los Angeles; Oregon Health & Science University; University of California, San Diego; University of California, Berkeley; Seattle Children’s Hospital; Cedars-Sinai Accelerator; LA BioMed; and Project Zygote.
“Our mission is to improve health outcomes for our vulnerable pediatric population,” Juan Espinoza, MD, FAAP, a general pediatrician at CHLA and co-director of the CTIP, said in the press release. “To be recognized by the FDA as a center of excellence for pediatric innovation and to serve as a national resource for pediatric device development is both a great honor and great responsibility. We feel fortunate to be working with some of the finest institutions on the West Coast to support and foster collaboration in medical technology development.”